• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性肝癌患者肠内营养的效果:一项随机对照研究方案。

The effectiveness of enteral nutrition for patients with primary liver cancer: A randomized controlled study protocol.

机构信息

Department of general surgery, Chun' an County First People's Hospital, Zhejiang, China.

出版信息

Medicine (Baltimore). 2021 Jan 22;100(3):e23973. doi: 10.1097/MD.0000000000023973.

DOI:10.1097/MD.0000000000023973
PMID:33545982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7837949/
Abstract

OBJECTIVE

: The objective of this study is to explore the influence of the enteral nutrition on primary liver cancer patients after receiving hepatectomy.

METHOD

: This is a prospective randomized controlled research, which will be conducted between April 2021 and April 2022. Approval is obtained from the Research Ethics Committee of Chun’ an County First People's Hospital (A20201108). Patients who meet the following conditions will be included in this experiment: (1).. the patients aged 18 to 70 years; (2).. in line with clinical diagnostic criteria for primary liver cancer; (3).. planned liver resection for primary liver cancer; (4).. liver function status of Child-Pugh A. Patients with the following characteristics are excluded: (1).. a history of other malignancy; (2).. mental disorder; (3).. severe diabetes or poor glycemic control; (4).. serious complications: bleeding and bile leakage; (5).. poor medical condition: renal failure, respiratory or heart failure. Our investigation includes sixty patients who meet our inclusion criteria. The primary endpoints are length of postoperative hospital stay and liver function index. The secondary results involve the first flatus time and the first defecation time.

RESULTS

: Table 1 indicates the postoperative outcomes between treatment group and control group.

CONCLUSION

: Enteral nutrition can improve recovery in the primary liver cancer patients after receiving hepatectomy.

TRIAL REGISTRATION

: The protocol has been registered in Research Registry (researchregistry6275)

摘要

目的

本研究旨在探讨肝切除术后肠内营养对原发性肝癌患者的影响。

方法

这是一项前瞻性随机对照研究,将于 2021 年 4 月至 2022 年 4 月进行。本研究获得淳安县第一人民医院伦理委员会的批准(A20201108)。符合以下条件的患者将纳入本实验:(1)年龄 18-70 岁;(2)符合原发性肝癌的临床诊断标准;(3)原发性肝癌行肝切除术;(4)肝功能状态为 Child-Pugh A。具有以下特征的患者将被排除:(1)其他恶性肿瘤病史;(2)精神障碍;(3)严重糖尿病或血糖控制不佳;(4)严重并发症:出血和胆漏;(5)身体状况不佳:肾衰竭、呼吸或心力衰竭。我们的调查包括 60 名符合纳入标准的患者。主要终点是术后住院时间和肝功能指标。次要结果包括首次肛门排气时间和首次排便时间。

结果

表 1 显示了治疗组和对照组之间的术后结果。

结论

肝切除术后肠内营养可促进原发性肝癌患者的康复。

试验注册

该方案已在 Research Registry(researchregistry6275)上注册。

相似文献

1
The effectiveness of enteral nutrition for patients with primary liver cancer: A randomized controlled study protocol.原发性肝癌患者肠内营养的效果:一项随机对照研究方案。
Medicine (Baltimore). 2021 Jan 22;100(3):e23973. doi: 10.1097/MD.0000000000023973.
2
Enteral nutritional therapy for induction of remission in Crohn's disease.肠内营养疗法诱导克罗恩病缓解
Cochrane Database Syst Rev. 2007 Jan 24(1):CD000542. doi: 10.1002/14651858.CD000542.pub2.
3
Is enteral nutrition a primary therapy in cancer patients?肠内营养是癌症患者的主要治疗方法吗?
Gut. 1994 Jan;35(1 Suppl):S65-8. doi: 10.1136/gut.35.1_suppl.s65.
4
Do data support nutrition support? Part II. enteral artificial nutrition.数据是否支持营养支持?第二部分。肠内人工营养。
J Am Diet Assoc. 2007 Aug;107(8):1374-80. doi: 10.1016/j.jada.2007.05.006.
5
Early Enteral Nutrition Provided Within 24 Hours of ICU Admission: A Meta-Analysis of Randomized Controlled Trials.ICU 入院 24 小时内提供早期肠内营养:一项随机对照试验的荟萃分析。
Crit Care Med. 2018 Jul;46(7):1049-1056. doi: 10.1097/CCM.0000000000003152.
6
Comparison of continuous versus intermittent enteral nutrition in critically ill patients (COINN): study protocol for a randomized comparative effectiveness trial.比较危重症患者连续与间断肠内营养(COINN):一项随机对照有效性试验的研究方案。
Trials. 2020 Nov 23;21(1):955. doi: 10.1186/s13063-020-04866-2.
7
Enteral nutrition in acute pancreatitis.急性胰腺炎的肠内营养
Nutr Rev. 1997 Jul;55(7):279-82. doi: 10.1111/j.1753-4887.1997.tb01618.x.
8
Early Enteral Nutrition Reduces Mortality and Improves Other Key Outcomes in Patients With Major Burn Injury: A Meta-Analysis of Randomized Controlled Trials.早期肠内营养可降低大面积烧伤患者的死亡率并改善其他关键结局:一项随机对照试验的荟萃分析。
Crit Care Med. 2018 Dec;46(12):2036-2042. doi: 10.1097/CCM.0000000000003445.
9
Enteral nutrition and the risk of mortality and infectious complications in patients with severe acute pancreatitis: a meta-analysis of randomized trials.肠内营养与重症急性胰腺炎患者的死亡率及感染性并发症风险:一项随机试验的荟萃分析
Arch Surg. 2008 Nov;143(11):1111-7. doi: 10.1001/archsurg.143.11.1111.
10
Enteral immunonutrition versus standard enteral nutrition for patients undergoing oesophagogastric resection for cancer.癌症患者行食管胃切除术时肠内免疫营养与标准肠内营养的比较。
Int J Surg. 2013;11(2):122-7. doi: 10.1016/j.ijsu.2012.12.012. Epub 2012 Dec 26.

引用本文的文献

1
Quality of Life of Cancer Patients Receiving Enteral Nutrition: A Systematic Review of Randomized Controlled Trials.癌症患者接受肠内营养的生活质量:随机对照试验的系统评价。
Nutrients. 2021 Dec 19;13(12):4551. doi: 10.3390/nu13124551.

本文引用的文献

1
The changing epidemiology of primary liver cancer.原发性肝癌不断变化的流行病学。
Curr Epidemiol Rep. 2019 Jun;6(2):104-111. doi: 10.1007/s40471-019-00188-3. Epub 2019 May 3.
2
Systemic Therapy for Hepatocellular Carcinoma: Latest Advances.肝细胞癌的全身治疗:最新进展
Cancers (Basel). 2018 Oct 30;10(11):412. doi: 10.3390/cancers10110412.
3
Exploring liver physiology, pathology, TGF-β, EMT, stemness and new developments in liver cancer.探索肝脏生理学、病理学、转化生长因子-β、上皮-间质转化、干性以及肝癌的新进展。
Hepat Oncol. 2017 Jan;4(1):9-13. doi: 10.2217/hep-2017-0007. Epub 2017 Jul 6.
4
A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial.一种多菌株益生菌可降低非酒精性脂肪性肝病患者的脂肪肝指数、细胞因子和转氨酶水平:一项随机临床试验的证据。
J Gastrointestin Liver Dis. 2018 Mar;27(1):41-49. doi: 10.15403/jgld.2014.1121.271.kby.
5
Nutritional support and parenteral nutrition in cancer patients: an expert consensus report.肿瘤患者的营养支持与肠外营养:专家共识报告。
Clin Transl Oncol. 2018 May;20(5):619-629. doi: 10.1007/s12094-017-1757-4. Epub 2017 Oct 17.
6
The diagnosis and treatment of hepatocellular carcinoma.肝细胞癌的诊断与治疗
Semin Diagn Pathol. 2017 Mar;34(2):153-159. doi: 10.1053/j.semdp.2016.12.011. Epub 2016 Dec 20.
7
Surgery and Hepatocellular Carcinoma.手术与肝细胞癌
Liver Cancer. 2016 Nov;6(1):44-50. doi: 10.1159/000449344. Epub 2016 Nov 29.
8
Local ablative treatments for hepatocellular carcinoma: An updated review.肝细胞癌的局部消融治疗:最新综述。
World J Gastrointest Pharmacol Ther. 2016 Nov 6;7(4):477-489. doi: 10.4292/wjgpt.v7.i4.477.
9
Enteral and parenteral nutrition in cancer patients: a systematic review and meta-analysis.癌症患者的肠内和肠外营养:一项系统评价和荟萃分析。
Ann Palliat Med. 2016 Jan;5(1):30-41. doi: 10.3978/j.issn.2224-5820.2016.01.01.
10
Hepatocellular carcinoma and lifestyles.肝细胞癌与生活方式。
J Hepatol. 2016 Jan;64(1):203-14. doi: 10.1016/j.jhep.2015.08.028. Epub 2015 Sep 1.